Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record now presents information about the KEYNOTE-183 multiple myeloma trial, including its treatment arms, eligibility criteria, outcome measures, results, and study documents.
    Difference
    53%
    Check dated 2026-11-07T16:42:40.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.2 to v3.8.0, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T16:53:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    An NIH announcement banner was added, describing updates to terminology used across NIH content. The study page itself continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-24T22:15:20.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:46.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:04:51.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error with minimal HTML markup, replacing the expected study content. This indicates access to the page is blocked rather than a change to the study data.
    Difference
    19%
    Check dated 2026-09-19T20:49:27.000Z thumbnail image

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.